Assessment and Management

CME

Obesity as a Cardiovascular Risk Factor: Assessment and Management

Physicians: Maximum of 1.50 Medical Knowledge MOC points

Physicians: Maximum of 1.50 AMA PRA Category 1 Credits™

Released: December 14, 2022

Expiration: December 14, 2023

Jean-Pierre Després
Jean-Pierre Després, CQ, PhD, FAHA, FIAS
Ian Neeland
Ian Neeland, MD, FAHA, FACC
Fatima Cody Stanford
Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS

Pretest

Progress
1 2
Course Completed
1.

How confident are you in developing personalized plans to manage obesity in patients with cardiovascular disease?

2.

Which of the following is a cardiovascular effect of obesity?

3.

Dan is a 56-year-old man recently diagnosed with ASCVD; he also has T2DM, HTN, and dyslipidemia. His BMI is 32 kg/m2. He wants to lower his risk of further CV events and asks you for  your thoughts on weight loss to achieve this goal. What do you tell him?

4.

A meta-analysis of the cardiovascular and renal outcomes for GLP-1 RAs found that they significantly reduced which of the following?

5.

Dan, the patient previously discussed who has a BMI of 32 kg/m2, has been following a Mediterranean diet and walking for 30 minutes 5 days/week for 3 months and has lost only 1 lb. He wants to know about pharmacotherapy and bariatric surgery. What do you tell him?